Target intelligence / Profile preview

Off-target cellular messenger RNAs with seed-region complementarity

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Off-target cellular messenger RNAs (mRNAs) with seed-region complementarity represent a major class of unintended targets for RNA interference (RNAi) therapeutics, such as small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs). This phenomenon occurs when the 'seed region' of the siRNA guide strand—typically nucleotides 2 through 8—binds to complementary sequences in the 3' untranslated regions (UTRs) of non-target mRNAs (Jackson et al., 2003, Nature Biotechnology). This interaction mimics the natural mechanism of microRNAs (miRNAs), leading to the degradation or translational repression of these unintended transcripts (Birmingham et al., 2006, Nature Methods). Because a single 7-nucleotide seed sequence can be present in hundreds of different cellular mRNAs, a single siRNA can potentially perturb the expression of many genes simultaneously. Such off-target effects are a primary concern in drug safety, as they can lead to cellular toxicity, altered metabolic pathways, or hepatotoxicity in clinical settings (Janas et al., 2018, Nature Communications). To mitigate these risks, researchers employ chemical modifications, such as 2'-O-methyl substitutions at position 2 of the guide strand, to reduce the binding affinity of the seed region while maintaining on-target potency. Understanding and predicting these interactions through bioinformatics and transcriptomic profiling is essential for the design of safe and specific RNA-based medicines.

Other names
Seed-mediated off-target effectsmiRNA-like off-target effectssiRNA off-target effectsUnintended mRNA silencing
02

Mechanism of action

Seed-mediated RNA interference (RNAi) leading to mRNA degradation or translational repression

03

Biological functions

Gene expression regulationProtein translationmRNA stability
04

Disease associations

Drug-induced toxicityAdverse drug reactions
05

Safety considerations

Off-target gene silencingHepatotoxicityCellular toxicitySequence-specific toxicity
06

Interacting drugs

Patisiran

4 more in the full profile.

07

Biomarkers

Transcriptome profilingRNA-seqReporter gene assays

Beyond the preview

Go deeper on Off-target cellular messenger RNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target cellular messenger RNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call